test

Harold Schaaff

@Soleus Capital Management, L.p.

Latest period2024 - Q3ReportedManaged Assets$1.291BTotal holdings87
Assets growth rate13.9%Assets growth rate (2-Q avg)-0.97%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Soleus Capital Management, L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 87 positions.

Assets under management

The assets under management (AUM) of Soleus Capital Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.291B in assets, with a quarterly growth rate of 13.9% and a 2-quarter average growth rate of -0.97%. The portfolio is managed by Harold Schaaff, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
SKINThe Beauty Health Company
Recent Activity
Exited
0%
$3.081M
1.605M shares@ $1.93 avg price
FATEFate Therapeutics Inc
Recent Activity
Exited
0%
$2.854M
870,000 shares@ $3.28 avg price
XFORX4 Pharmaceuticals Inc
Recent Activity
Exited
0%
$2.35M
4.051M shares@ $0.58 avg price
JANXJanux Therapeutics Inc
Recent Activity
Exited
0%
$2.325M
55,500 shares@ $41.89 avg price
FDMT4d Molecular Therapeutics In
Recent Activity
Exited
0%
$2.279M
108,598 shares@ $20.99 avg price
WGSGenedx Holdings Corp
Recent Activity
Exited
0%
$2.274M
87,000 shares@ $26.14 avg price
RCELAvita Medical Inc
Recent Activity
Exited
0%
$2.115M
267,000 shares@ $7.92 avg price
NVCRNovocure Ltd
Recent Activity
Exited
0%
$1.865M
108,900 shares@ $17.13 avg price
INBXInhibrx Biosciences Inc
Recent Activity
Exited
0%
$1.254M
88,470 shares@ $14.18 avg price
ORICOric Pharmaceuticals Inc
Recent Activity
Exited
0%
$1.152M
163,000 shares@ $7.07 avg price